Robust Kidney Abnormality Segmentation: A Validation Study of an AI-Based Framework
Sarah de Boer, Hartmut Häntze, Kiran Vaidhya Venkadesh, Myrthe A. D. Buser, Gabriel E. Humpire Mamani, Lina Xu, Lisa C. Adams, Jawed Nawabi, Keno K. Bressem, Bram van Ginneken, Mathias Prokop, Alessa Hering
TL;DR
The study tackles the lack of robust, generalizable kidney abnormality segmentation by training a nnU-Net-based framework on two public datasets and validating on three external test sets totaling over 1,500 CT scans. It employs a preprocessing step with TotalSegmentator and careful post-processing, achieving superior segmentation and detection performance compared with TotalSegmentator and BAMF across diverse datasets and subgroups. The results show Dice improvements and competitive $HD_{95}$ distances, with performance approaching inter-observer variability for healthy kidneys and abnormalities on external data, underscoring clinical relevance. Public availability of the model and code supports immediate translation and further cross-institutional evaluation for volume-based biomarkers and automated kidney diagnostics.
Abstract
Kidney abnormality segmentation has important potential to enhance the clinical workflow, especially in settings requiring quantitative assessments. Kidney volume could serve as an important biomarker for renal diseases, with changes in volume correlating directly with kidney function. Currently, clinical practice often relies on subjective visual assessment for evaluating kidney size and abnormalities, including tumors and cysts, which are typically staged based on diameter, volume, and anatomical location. To support a more objective and reproducible approach, this research aims to develop a robust, thoroughly validated kidney abnormality segmentation algorithm, made publicly available for clinical and research use. We employ publicly available training datasets and leverage the state-of-the-art medical image segmentation framework nnU-Net. Validation is conducted using both proprietary and public test datasets, with segmentation performance quantified by Dice coefficient and the 95th percentile Hausdorff distance. Furthermore, we analyze robustness across subgroups based on patient sex, age, CT contrast phases, and tumor histologic subtypes. Our findings demonstrate that our segmentation algorithm, trained exclusively on publicly available data, generalizes effectively to external test sets and outperforms existing state-of-the-art models across all tested datasets. Subgroup analyses reveal consistent high performance, indicating strong robustness and reliability. The developed algorithm and associated code are publicly accessible at https://github.com/DIAGNijmegen/oncology-kidney-abnormality-segmentation.
